HemaSphere (Aug 2023)

P928: OCULAR ADVERSE EVENTS AND FUNCTIONAL IMPACT IN TRANSPLANT INELIGIBLE, NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH BELANTAMAB MAFODOTIN, LENALIDOMIDE AND DEXAMETHASONE IN A PHASE 1/2 TRIAL

  • Evangelos Terpos,
  • Ioannis Ntanasis-Stathopoulos,
  • Maria Gavriatopoulou,
  • Panagiotis Malandrakis,
  • Despina Fotiou,
  • Magdalini Migkou,
  • Foteini Theodorakakou,
  • Vasiliki Spiliopoulou,
  • Rodanthi Syrigou,
  • Evangelos Eleutherakis-Papaiakovou,
  • Stavros Gkolfinopoulos,
  • Kyriaki Manousou,
  • Efstathios Kastritis,
  • Meletios A. Dimopoulos

DOI
https://doi.org/10.1097/01.HS9.0000970616.80080.6b
Journal volume & issue
Vol. 7
p. e800806b

Abstract

Read online

No abstracts available.